Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: A prospective comparative study

Journal of Chemotherapy

Volumn 10, Issue 4, 1998, Pages 331-338

  Tsavaris, N ^a,c   Tentas, K ^d   Tzivras, M ^a   Kosmas, C ^a   Kalachanis, N ^b   Katsikas, M ^a   Dimitrakopoulos, A ^a   Papastratis, G ^b   Macheras, A ^b   Karatzas, G ^b   Sechas, M ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d NONE

Author keywords

5 Fluorouracil; Epirubicin; Folinic acid; Pancreatic cancer

Indexed keywords

EPIRUBICIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; PANCREAS CANCER; QUALITY OF LIFE; VOMITING;

EID: 15644362776     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.4.331     Document Type: Article

References (18)

1. Brown TD, Gastrointestinal Cancer. In Weiss GR, Clinical Oncology, Lange Medical Book, Connecticut, USA. 1993.
2. Ahlgren JD. Chemotherapy for pancreatic carcinoma. Cancer 1996; 78: 654-663.
3. Bolli E, Saccomano S, Mondini G, et al. 5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. Cancer Chemother Pharmacol 1995; 35: 339-342.
4. MacDonald JS, Schein PS, Wooley PV. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980; 93: 533-536.
5. Formasiero A, Cartei G, Daniele O, et al. FAM2 regimen in disseminated gastric cancer. Tumori 1984; 70: 77-80.
6. Takada T, Kato H, Matsushiro T, et al. Prospective randomized trial comparing 1/2 FAM (5-fluorouracil + Adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas. Gan To Kagaku Ryoho 1996; 23: 707-714.
7. Karlin DA, Strochlein JR, Bennetts RW, et al. Phase I-II study of the combination of 5-FU, doxorubicin, mitomycin, and semustin (FAMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Cancer Treat Rep 1982; 66: 1613-1617.
8. Preusser P, Wilke H, Achterrath W, et al. Phase I-II study with EAP (etoposide, Adriamycin, cisplatin) in advanced gastric cancer, abstract. Proc EORTC Symposium on Gastrointestinal Tract Cancer. Update on Combined Modality Treatment. Heidelberg, 1986.
9. Klein HO, Dias Wickramanayake P, Farrokh GH, 5-Fluorouracil, Adriamycin, and methotrexate - a combined protocol (FAMTX) for the treatment of metastasized stomach cancer. Proc ASCO 1986; 5: 84.
10. Moertel CG, Rubin J, O'Connel MJ, Schutt AJ. Wieand HS. A phase Il study of combined 5-fluorouracil.doxorubicin,and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol 1986; 4: 1053-1057.
11. Machover D, Goldschmidt E, Chollet P, Metzger G, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high dose folinic acid. NCI Monogr 1987; (5): 193-198.
12. Cunningham D, Gilchrist NL, Forrest GJ, et al. Chemotherapy in advanced gastric cancer. Cancer Treat Rep 1985; 69: 927-928.
13. Tsavaris N, Mylonakis N, Bacoyiannis Ch, et al. Combined epirubicin, 5-fluorouracil, leucovorin, with allopurinol protection in the treatment of advanced gastric cancer. A pilot study. Onkologie 1995; 18: 346-350.
14. Miller A, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-217.
15. Kaplan EL, Meier P. Non parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
17. Schnall SF, MacDonald JS. Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol 1996; 23: 220-228.
18. Glimelius B, Hoffman K, Sjoden PO. et al. Chemotherapy improves survival in advanced pancreatic and biliary cancer. Ann Oncol 1996; 7: 593-600.